SCHWABE STEFAN K.F. (Executive Vice President R&D) sold 94.4% of their position (46.35K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.02M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/22/2020ACC: 0001104659-20-138671
Officer· Executive Vice President R&D
Since Feb 2019
-46.35K
Net shares
Net seller
$1.02M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
46.35K acquired · 92.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+46.35K
Price / share
$12.98
Trade value
$601.58K
% of position
1672.0%
12/21/2020
2.77K→49.12K
Common Stock
Direct
Shares
−46.35K
Price / share
$22.10
Trade value
$1.02M
% of position
94.4%
12/21/2020
49.12K→2.77K
Total
Net shares
+0.00
Net value
-$422.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/21/2020 | M · Option Exercise | +46.35K | $12.98 | $601.58K | 1672.0% | 2.77K | 49.12K |
| Common Stock Direct | 12/21/2020 | S · Sale | −46.35K | $22.10 | $1.02M | 94.4% | 49.12K | 2.77K |
| Total | +0.00 | -$422.88K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
46.35K shares
Shares
−46.35K
Strike price
12.98
Held after
0.00
Exercisable
—
12/21/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock46.35K shares | 12/21/2020 | M · Option Exercise | −46.35K | 12.98 | — | 0.00 |